person
Cécile Edith V.
- Country
- France
- Department
- Oncology
Research Overview
assignment
3
Clinical Trials ·
- Phase I/Ib Clinical Evaluation of PM54 in Patients with Advanced Solid Tumors
- A Phase 1/2 Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of BLU-222 as a Single Agent and in Combination Therapy for Patients with Advanced Solid Tumors
- Dose Escalation and Cohort Expansion Study of KB-0742 in Relapsed or Refractory Solid Tumors and Non-Hodgkin Lymphoma
location_city
1
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
11
Sites with multiple studies
Has run more than one trial at 11 of 33 partner sites.
Specializations
Advanced Cancer Research
The investigator specializes in studying advanced and metastatic solid tumors, with particular emphasis on innovative therapeutic approaches for patients with limited treatment options.
- Locally advanced tumors
- Metastatic malignancies
- Refractory solid tumors
Targeted Therapies
Focuses on developing treatments targeting specific molecular pathways, including HER2-expressing cancers and tumors with KRAS G12C mutations.
- Breast cancer therapeutics
- Gastric cancer treatments
- FGFR alterations
Combination Therapies
Investigates novel drug combinations and immunotherapy approaches, particularly in the context of antibody-drug conjugates and targeted treatments.
- Monotherapy evaluations
- Immunotherapy combinations
- Multi-drug regimens
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.